SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028548
Filing Date
2019-08-05
Accepted
2019-08-05 09:23:03
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-10q_20190630.htm 10-Q 1305600
2 EX-31.1 krys-ex311_6.htm EX-31.1 23529
3 EX-31.2 krys-ex312_7.htm EX-31.2 23155
4 EX-32.1 krys-ex321_8.htm EX-32.1 18253
  Complete submission text file 0001564590-19-028548.txt   4516730

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20190630.xml EX-101.INS 903740
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20190630.xsd EX-101.SCH 31485
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20190630_cal.xml EX-101.CAL 35759
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20190630_def.xml EX-101.DEF 97422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20190630_lab.xml EX-101.LAB 271990
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20190630_pre.xml EX-101.PRE 211690
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 19997724
SIC: 2836 Biological Products, (No Diagnostic Substances)